New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Aspenbio Pharma Inc (APPY)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
7275
27.2K
10.7K
16.9K
18.7K
Cost of Revenue
184
12.0
0
396
0
Gross Profit
7091
27.2K
10.7K
16.5K
18.7K
Research & Development
677K
881K
1.07M
1.22M
1.41M
SG&A
1.20M
1.39M
1.35M
1.24M
1.43M
Amortization & Deprec
112K
112K
106K
79.4K
68.2K
Other Expenses
-112K
-112K
-106K
6.63M
-68.2K
Total Operating Expenses
1.88M
2.27M
2.41M
9.16M
2.84M
Operating Income
-1.87M
-2.25M
-2.40M
-9.15M
-2.82M
Other Income
0
336
-459
-1732
19.1K
EBIT
-1.87M
-2.25M
-2.40M
-9.15M
-2.80M
Minority Interest
0
0
0
0
0
Interest Expense
64.1K
63.0K
58.0K
63.6K
0
Income Before Taxes
-1.94M
-2.31M
-2.46M
-9.21M
-2.80M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-1.94M
-2.31M
-2.46M
-9.21M
-2.80M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-1.94M
-2.31M
-2.46M
-9.21M
-2.80M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-1.94M
-2.31M
-2.46M
-2.50M
-2.80M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour